SONIA ALONSO MARTÍN-rekin lankidetzan egindako argitalpenak (9)

2011

  1. Diminished thrombogenic responses by deletion of the Podocalyxin gene in mouse megakaryocytes

    PLoS ONE, Vol. 6, Núm. 10

2010

  1. Overexpression of podocalyxin in megakaryocytes and platelets decreases the bleeding time and enhances the agonist-induced aggregation of platelets

    Thrombosis Research, Vol. 125, Núm. 6

  2. Ventricular enlargement associated with the panneural ablation of the podocalyxin gene

    Molecular and Cellular Neuroscience, Vol. 43, Núm. 1, pp. 90-97

2008

  1. Expression of podocalyxin enhances the adherence, migration, and intercellular communication of cells

    Experimental Cell Research, Vol. 314, Núm. 10, pp. 2004-2015

2007

  1. Podocalyxin enhances the adherence of cells to platelets

    Cellular and Molecular Life Sciences, Vol. 64, Núm. 22, pp. 2965-2974

2006

  1. Production and characterization of murine monoclonal antibodies against human podocalyxin

    Tissue Antigens, Vol. 68, Núm. 5, pp. 407-417

  2. Role of transcription factor Sp1 and CpG methylation on the regulation of the human podocalyxin gene promoter

    BMC Molecular Biology, Vol. 7

2004

  1. A variant thrombasthenic phenotype associated with compound heterozygosity of integrin β3-subunit: (Met124Val)β 3 alters the subunit dimerization rendering a decreased number of constitutive active αIIbβ3 receptors

    Thrombosis and Haemostasis, Vol. 92, Núm. 6, pp. 1377-1386

  2. α-adrenergic-mediated activation of human reconstituted fibrinogen receptor (integrin αIIbβ3) in Chinese hamster ovary cells

    Thrombosis and Haemostasis, Vol. 92, Núm. 6, pp. 1368-1376